BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang SY, Hu HZ, Qing XC, Zhang ZC, Shao ZW. Recent advances of drug delivery nanocarriers in osteosarcoma treatment. J Cancer 2020;11:69-82. [PMID: 31892974 DOI: 10.7150/jca.36588] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen C, Wang S, Wang J, Yao F, Tang X, Guo W. Nanosized drug delivery strategies in osteosarcoma chemotherapy. APL Bioeng 2023;7:011501. [PMID: 36845905 DOI: 10.1063/5.0137026] [Reference Citation Analysis]
2 Giordano F, Lenna S, Baudo G, Rampado R, Massaro M, De Rosa E, Ewing A, Kurenbekova L, Agostini M, Yustein JT, Taraballi F. Tyrosine kinase inhibitor-loaded biomimetic nanoparticles as a treatment for osteosarcoma. Cancer Nano 2022;13:40. [DOI: 10.1186/s12645-022-00146-7] [Reference Citation Analysis]
3 Montiel-centeno K, García-villén F, Barrera D, Amaya-roncancio S, Sánchez-espejo R, Arroyo-gómez JJ, Sandri G, Viseras C, Sapag K. Biocompatible nanoporous carbons as a carrier system for controlled release of cephalexin. Colloids and Surfaces B: Biointerfaces 2022;220:112937. [DOI: 10.1016/j.colsurfb.2022.112937] [Reference Citation Analysis]
4 Swidan MM, Abd El-motaleb M, Sakr TM. Unraveling the diagnostic phase of 99mTc-doped iron oxide nanoprobe in sarcoma bearing mice. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103990] [Reference Citation Analysis]
5 Zhang X, Chen H, Zhang Y, Huang Q, Feng J, Xing H, Fu X, Yan X, Zhang Y, Xu Q, Liang J. HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma. IJN 2022;Volume 17:5137-5151. [DOI: 10.2147/ijn.s371934] [Reference Citation Analysis]
6 Marshall SK, Saelim B, Taweesap M, Pachana V, Panrak Y, Makchuchit N, Jaroenpakdee P. Anti-EGFR Targeted Multifunctional I-131 Radio-Nanotherapeutic for Treating Osteosarcoma: In Vitro 3D Tumor Spheroid Model. Nanomaterials (Basel) 2022;12. [PMID: 36234645 DOI: 10.3390/nano12193517] [Reference Citation Analysis]
7 Jesús Villarreal-gómez L, Lizeth Pérez-gonzález G. Novel Drug Carries: Properties and Applications. Drug Carriers [Working Title] 2022. [DOI: 10.5772/intechopen.106868] [Reference Citation Analysis]
8 Zhang Y, Wu Y, Qiao X, Lin T, Wang Y, Wang M. Biomaterial-based strategy for bone tumor therapy and bone defect regeneration: An innovative application option. Front Mater 2022;9:990931. [DOI: 10.3389/fmats.2022.990931] [Reference Citation Analysis]
9 Jing Z, Yang J, Liang Z, Du W, Yu T, Wei W. Hydroxysteroid Dehydrogenase Like 2 Promotes the Invasion and Migration of Osteosarcoma by Regulating Fibroblast Growth Factor Receptor 4. j biomater tissue eng 2022;12:1818-1824. [DOI: 10.1166/jbt.2022.3110] [Reference Citation Analysis]
10 Jiang J, Wang R, Yang L, Sha Y, Zhao S, Guo J, Chen D, Zhong Z, Meng F. IL-11Rα-targeted nanostrategy empowers chemotherapy of relapsed and patient-derived osteosarcoma. J Control Release 2022:S0168-3659(22)00555-7. [PMID: 36041590 DOI: 10.1016/j.jconrel.2022.08.048] [Reference Citation Analysis]
11 Dhilip Kumar SS, Abrahamse H. Recent advances in the development of biocompatible nanocarriers and their cancer cell targeting efficiency in photodynamic therapy. Front Chem 2022;10:969809. [DOI: 10.3389/fchem.2022.969809] [Reference Citation Analysis]
12 Bai B, Weng S, Wu Z, Xie Z, Tang J, Yang Q. Fabrication of Dual-Responsive pH and Reduction of Dual Anticancer Drugs Conjugates Dextran Self-Assembly for Osteosarcoma Cancer Treatment. Process Biochemistry 2022. [DOI: 10.1016/j.procbio.2022.08.005] [Reference Citation Analysis]
13 Vallet-Regí M, Schüth F, Lozano D, Colilla M, Manzano M. Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? Chem Soc Rev 2022. [PMID: 35642539 DOI: 10.1039/d1cs00659b] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
14 Pandey S. Advance Nanomaterials for Biosensors. Biosensors (Basel) 2022;12:219. [PMID: 35448278 DOI: 10.3390/bios12040219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Tang J, Duan G, Wang Y, Wang B, Li W, Zhu Z. Circular RNA_ANKIB1 accelerates chemo-resistance of osteosarcoma via binding microRNA-26b-5p and modulating enhancer of zeste homolog 2. Bioengineered 2022;13:7351-66. [PMID: 35264070 DOI: 10.1080/21655979.2022.2037869] [Reference Citation Analysis]
16 Wu K, Yu B, Li D, Tian Y, Liu Y, Jiang J. Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma. Front Oncol 2022;12:805978. [PMID: 35242707 DOI: 10.3389/fonc.2022.805978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Xie D, Wang Z, Li J, Guo D, Lu A, Liang C. Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment. Front Oncol 2022;12:843345. [DOI: 10.3389/fonc.2022.843345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Cai J, Liu J, Wu J, Li Y, Qiu X, Xu W, Xu P, Xiang D. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma. IJN 2022;Volume 17:837-54. [DOI: 10.2147/ijn.s346685] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
19 da Silva Bruckmann F, Viana AR, Lopes LQS, Santos RCV, Muller EI, Mortari SR, Rhoden CRB. Synthesis, Characterization, and Biological Activity Evaluation of Magnetite-Functionalized Eugenol. J Inorg Organomet Polym. [DOI: 10.1007/s10904-021-02207-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kausar A. Cutting-edge polymer/graphene nanocomposites for biomedical applications. Graphene to Polymer/Graphene Nanocomposites 2022. [DOI: 10.1016/b978-0-323-90937-2.00011-3] [Reference Citation Analysis]
21 Aslani R, Namazi H. Simple fabrication of multifunctional hyperbranched copolymer based on l-lysine and citric acid for co-delivery of anticancer drugs to breast cancer cells. Reactive and Functional Polymers 2022;170:105101. [DOI: 10.1016/j.reactfunctpolym.2021.105101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Guo J, Li X, Shen S, Wu X. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes. Sci Rep 2021;11:24123. [PMID: 34916564 DOI: 10.1038/s41598-021-03677-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Lian J, Casari I, Falasca M. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. Pharmacol Res 2021;175:106025. [PMID: 34883211 DOI: 10.1016/j.phrs.2021.106025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Pan X, Cheng D, Ruan C, Hong Y, Lin C. Development of Graphene‐Based Materials in Bone Tissue Engineaering. Global Challenges. [DOI: 10.1002/gch2.202100107] [Reference Citation Analysis]
25 He J, Zhang W, Zhou X, Yan W, Wang Z. Aloin induced apoptosis by enhancing autophagic flux through the PI3K/AKT axis in osteosarcoma. Chin Med 2021;16:123. [PMID: 34819120 DOI: 10.1186/s13020-021-00520-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Visan AI, Ristoscu C, Popescu-Pelin G, Sopronyi M, Matei CE, Socol G, Chifiriuc MC, Bleotu C, Grossin D, Brouillet F, Grill SL, Bertrand G, Zgura I, Cristescu R, Mihailescu IN. Composite Drug Delivery System Based on Amorphous Calcium Phosphate-Chitosan: An Efficient Antimicrobial Platform for Extended Release of Tetracycline. Pharmaceutics 2021;13:1659. [PMID: 34683952 DOI: 10.3390/pharmaceutics13101659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Pandey AK, Piplani N, Mondal T, Katranidis A, Bhattacharya J. Efficient delivery of hydrophobic drug, Cabazitaxel, using Nanodisc: A nano sized free standing planar lipid bilayer. Journal of Molecular Liquids 2021;339:116690. [DOI: 10.1016/j.molliq.2021.116690] [Reference Citation Analysis]
28 Barik D, Dash P, Uma PI, Kumari S, Dash M. A Review on Re-Packaging of Bisphosphonates Using Biomaterials. J Pharm Sci 2021;110:3757-72. [PMID: 34474062 DOI: 10.1016/j.xphs.2021.08.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Liu Y, Raina DB, Sebastian S, Nagesh H, Isaksson H, Engellau J, Lidgren L, Tägil M. Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma. Acta Biomater 2021;131:555-71. [PMID: 34271171 DOI: 10.1016/j.actbio.2021.07.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
30 Bădilă AE, Rădulescu DM, Niculescu AG, Grumezescu AM, Rădulescu M, Rădulescu AR. Recent Advances in the Treatment of Bone Metastases and Primary Bone Tumors: An Up-to-Date Review. Cancers (Basel) 2021;13:4229. [PMID: 34439383 DOI: 10.3390/cancers13164229] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
31 Suleman A, Kondiah PPD, Mabrouk M, Choonara YE. The Application of 3D-Printing and Nanotechnology for the Targeted Treatment of Osteosarcoma. Front Mater 2021;8:668834. [DOI: 10.3389/fmats.2021.668834] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 He J, Ling L, Liu Z, Ren X, Wan L, Tu C, Li Z. Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma. Cancer Cell Int 2021;21:313. [PMID: 34130697 DOI: 10.1186/s12935-021-02013-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
33 Hattinger CM, Patrizio MP, Fantoni L, Casotti C, Riganti C, Serra M. Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers (Basel) 2021;13:2878. [PMID: 34207685 DOI: 10.3390/cancers13122878] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
34 Roy S, Mukherjee P, Das PK, Ghosh PR, Datta P, Kundu B, Nandi SK. Local delivery systems of morphogens/biomolecules in orthopedic surgical challenges. Materials Today Communications 2021;27:102424. [DOI: 10.1016/j.mtcomm.2021.102424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Sneha KR, Sreeja S, Sailaja GS. Radiopacity endowed magnetic nanocomposite with hyperthermia andin vitromineralization potential: a combinatorial therapeutic system for osteosarcoma. Biomed Mater 2021;16. [PMID: 34061045 DOI: 10.1088/1748-605X/ac01af] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Lim CW, Kim D. Bone targeting nano-aggregates prepared from self-assembled polyaspartamide graft copolymers for pH sensitive DOX delivery. Biomater Sci 2021;9:1660-7. [PMID: 33409517 DOI: 10.1039/d0bm01473g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
37 Zielińska A, Szalata M, Gorczyński A, Karczewski J, Eder P, Severino P, Cabeda JM, Souto EB, Słomski R. Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications. Cancers (Basel) 2021;13:1896. [PMID: 33920840 DOI: 10.3390/cancers13081896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
38 Debnath SK, Srivastava R. Drug Delivery With Carbon-Based Nanomaterials as Versatile Nanocarriers: Progress and Prospects. Front Nanotechnol 2021;3:644564. [DOI: 10.3389/fnano.2021.644564] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
39 Yu T, Liang S, Ma T, Song W. Downregulation of miR-588 is associated with tumor progression and unfavorable prognosis in patients with osteosarcoma. Exp Ther Med 2021;21:592. [PMID: 33884030 DOI: 10.3892/etm.2021.10024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Kaps A, Gwiazdoń P, Chodurek E. Nanoformulations for Delivery of Pentacyclic Triterpenoids in Anticancer Therapies. Molecules 2021;26:1764. [PMID: 33801096 DOI: 10.3390/molecules26061764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
41 Zhao X, Wu Q, Gong X, Liu J, Ma Y. Osteosarcoma: a review of current and future therapeutic approaches. Biomed Eng Online 2021;20:24. [PMID: 33653371 DOI: 10.1186/s12938-021-00860-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 20.0] [Reference Citation Analysis]
42 Sarma A, Bania R, Devi JR, Deka S. Therapeutic nanostructures and nanotoxicity. J Appl Toxicol 2021;41:1494-517. [PMID: 33641187 DOI: 10.1002/jat.4157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
43 Koçal G, Oktay B, Eroğlu GÖ, Kuruca SE, Çubuk S, Apohan NK. Stimuli-responsive smart nanoparticles with well-defined random and triblock terpolymers for controlled release of an anticancer drug. Materials Today Communications 2021;26:101974. [DOI: 10.1016/j.mtcomm.2020.101974] [Reference Citation Analysis]
44 Xu H, Zou X, Xia P, Huang H, Liu F, Ramesh T. Osteoblast cell viability over ultra-long tricalcium phosphate nanocrystal-based methacrylate chitosan composite for bone regeneration. Biomed Mater 2021. [PMID: 33618343 DOI: 10.1088/1748-605X/abe8ac] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Barani M, Mukhtar M, Rahdar A, Sargazi S, Pandey S, Kang M. Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Human Osteosarcoma. Biosensors (Basel) 2021;11:55. [PMID: 33672770 DOI: 10.3390/bios11020055] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 20.0] [Reference Citation Analysis]
46 Sreeja S, Parameshwar R, Varma PRH, Sailaja GS. Hierarchically Porous Osteoinductive Poly(hydroxyethyl methacrylate-co-methyl methacrylate) Scaffold with Sustained Doxorubicin Delivery for Consolidated Osteosarcoma Treatment and Bone Defect Repair. ACS Biomater Sci Eng 2021;7:701-17. [PMID: 33395260 DOI: 10.1021/acsbiomaterials.0c01628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 郝 亚. Autophagy-Mediated Chemotherapy Resistance of Gastric Cancer. ACM 2021;11:4499-4506. [DOI: 10.12677/acm.2021.1110660] [Reference Citation Analysis]
48 Gu M, Jiang L, Hao L, Lu J, Liu Z, Lei Z, Li Y, Hua C, Li W, Li X. A novel theranostic nanoplatform for imaging-guided chemo-photothermal therapy in oral squamous cell carcinoma. J Mater Chem B 2021;9:6006-16. [PMID: 34282440 DOI: 10.1039/d1tb01136g] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
49 Silva JV, Santos SDS, Sanches LM, Ferreira EI, Giarolla J. Advances in targeted dendrimers for cancer therapy and challenges for clinical translation. Dendrimer-Based Nanotherapeutics 2021. [DOI: 10.1016/b978-0-12-821250-9.00003-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Pan Y, Paschoalino WJ, Szuchmacher Blum A, Mauzeroll J. Recent Advances in Bio-Templated Metallic Nanomaterial Synthesis and Electrocatalytic Applications. ChemSusChem 2021;14:758-91. [PMID: 33296559 DOI: 10.1002/cssc.202002532] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
51 Wen X, Wang Q, Dai T, Shao J, Wu X, Jiang Z, Jacob JA, Jiang C. Identification of possible reductants in the aqueous leaf extract of mangrove plant Rhizophora apiculata for the fabrication and cytotoxicity of silver nanoparticles against human osteosarcoma MG-63 cells. Materials Science and Engineering: C 2020;116:111252. [DOI: 10.1016/j.msec.2020.111252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
52 Jafari F, Javdansirat S, Sanaie S, Naseri A, Shamekh A, Rostamzadeh D, Dolati S. Osteosarcoma: A comprehensive review of management and treatment strategies. Ann Diagn Pathol 2020;49:151654. [PMID: 33130384 DOI: 10.1016/j.anndiagpath.2020.151654] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 16.7] [Reference Citation Analysis]
53 Goodarzi K, Jonidi Shariatzadeh F, Solouk A, Akbari S, Mirzadeh H. Injectable drug loaded gelatin based scaffolds as minimally invasive approach for drug delivery system: CNC/PAMAM nanoparticles. European Polymer Journal 2020;139:109992. [DOI: 10.1016/j.eurpolymj.2020.109992] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
54 Lilienthal I, Herold N. Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies. Int J Mol Sci 2020;21:E6885. [PMID: 32961800 DOI: 10.3390/ijms21186885] [Cited by in Crossref: 64] [Cited by in F6Publishing: 75] [Article Influence: 21.3] [Reference Citation Analysis]
55 Bhatia R, Sharma A, Narang RK, Rawal RK. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy. Curr Mol Pharmacol 2021;14:350-66. [PMID: 32744982 DOI: 10.2174/1874467213666200730114943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Rothzerg E, Ingley E, Mullin B, Xue W, Wood D, Xu J. The Hippo in the room: Targeting the Hippo signalling pathway for osteosarcoma therapies. J Cell Physiol 2021;236:1606-15. [PMID: 32697358 DOI: 10.1002/jcp.29967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
57 Rodríguez-Nogales C, Moreno H, Zandueta C, Desmaële D, Lecanda F, Couvreur P, Blanco-Prieto MJ. Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma. Cancers (Basel) 2020;12:E1895. [PMID: 32674353 DOI: 10.3390/cancers12071895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Ghiasi B, Sefidbakht Y, Mozaffari-Jovin S, Gharehcheloo B, Mehrarya M, Khodadadi A, Rezaei M, Ranaei Siadat SO, Uskoković V. Hydroxyapatite as a biomaterial - a gift that keeps on giving. Drug Dev Ind Pharm 2020;46:1035-62. [PMID: 32476496 DOI: 10.1080/03639045.2020.1776321] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 10.3] [Reference Citation Analysis]
59 Liu L, Yan L, Liao N, Wu WQ, Shi JL. A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer. Cancers (Basel) 2020;12:E352. [PMID: 32033142 DOI: 10.3390/cancers12020352] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]